Litcius/Paper detail

Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial

Christopher Elnan Kvistad, Halvor Næss, Bernt Harald Helleberg, Titto Idicula, Guri Hagberg, Linn Marie Nordby, Kristian N Jenssen, Håkon Tobro, Dag Marius Rørholt, Kamaljit Kaur, Agnethe Eltoft, Kristin Evensen, Judit Haász, Guruparan Singaravel, Annette Fromm, Lars Thomassen

2022The Lancet Neurology205 citationsDOI

Topics & Concepts

TenecteplaseMedicineThrombolysisModified Rankin ScaleStroke (engine)Clinical endpointFibrinolytic agentTissue plasminogen activatorPopulationClinical trialIschaemic strokeRandomized controlled trialSurgeryInternal medicineMyocardial infarctionIschemic strokeIschemiaMechanical engineeringEngineeringEnvironmental healthAcute Ischemic Stroke ManagementProtease and Inhibitor MechanismsS100 Proteins and Annexins